Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2019-03-04
Product name
Amyvid
Product Synonyms
18F-AV-45 * Florbetapir F 18 Injection
1.2.1 Relevant identified uses
Radioactive diagnostic agent for Positron Emission Tomography (PET) imaging
Manufacturer Name
Eli Lilly and Company
Icons in SDS
Company Information
company name
Eli Lilly and Company
e-mail address of the competent person responsible for the Safety Data Sheet
lilly_msds@lilly.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
Physical hazards
Flammable liquids Category 3
Health hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Warning
Hazard statements
H226 Flammable liquid and vapor.
Prevention
P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking. P233 Keep container tightly closed. P241 Use explosion-proof electrical/ventilating/lighting equipment. P242 Use only non-sparking tools. P243 Take precautionary measures against static discharge. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P303 + P361 + P353 IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. P370 + P378 In case of fire: Use appropriate media to extinguish.
Storage
P403 + P235 Store in a well-ventilated place. Keep cool.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise RADIOACTIVE.
Additional information
This product is a radioactive diagnostic imaging agent containing Fluorine-18 and should be handled with appropriate safety measures to minimize radiation exposure during transport, storage, emergencies and administration. Radiopharmaceuticals should only be administered to humans under the control of physicians who are qualified by specific training and experience in the safe use and handling of radioactive materials, and whose experience and training have been approved by the appropriate governmental agency authorized to license the administration of radiopharmaceuticals.
